Elevated ALDOB levels correlate with unfavorable postoperative prognosis in CRC patients, colon cancer liver metastases, and response to neoadjuvant chemoradiotherapy in rectal cancer patients [19–21]. The gene discussed is ALDOB; the disease is malignant colon neoplasm.